NCT03518307

Brief Summary

The aim of this work is to study demographic, clinical, management (diagnostic and therapeutic) and survival data concerning patients with Merkel's carcinoma in the Lower Rhine, thus obtaining the first French data.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2017

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2017

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

April 25, 2018

Completed
13 days until next milestone

First Posted

Study publicly available on registry

May 8, 2018

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2018

Completed
Last Updated

May 8, 2018

Status Verified

April 1, 2018

Enrollment Period

1 year

First QC Date

April 25, 2018

Last Update Submit

April 25, 2018

Conditions

Merkel Carcinoma

Keywords

Merkel carcinoma

Outcome Measures

Primary Outcomes (1)

  • Retrospective study of demographic, clinical, management (diagnostic and therapeutic) and survival data for patients with Merkel carcinoma in the Lower Rhine region

    The period from from January 1st, 1983 to December 31st, 2011 will be examined

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients residing in the Bas-Rhin and diagnosed between 1983 and 2011 as having primitive Merkel arcinoma (topographic code C44 morphological code 8247/3)

You may qualify if:

  • Age \>18 years
  • Diagnosis of primary Merkel carcinoma (topographic code C44 morphological code 8247/3)
  • Diagnosis made between 1983 and 2011
  • Patient residing in the Bas-Rhin at the date of diagnosis
  • Patient who has given his consent for the use of his data for research purposes

You may not qualify if:

  • \- Refusal to participate in research

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Service de Dermatologie

Strasbourg, 67091, France

RECRUITING

Study Officials

  • Dan LIPSKER, MD, PhD

    University Hospital, Strasbourg, France

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Dan LIPSKER, MD, PhD

CONTACT

33.3.88.11.61.79dan.lipsker@chru-strasbourg.fr

Alice KIENY, MD

CONTACT

33.3.88.11.61.79Alice.KIENY@chru-strasbourg.fr

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 25, 2018

First Posted

May 8, 2018

Study Start

September 1, 2017

Primary Completion

September 1, 2018

Study Completion

September 1, 2018

Last Updated

May 8, 2018

Record last verified: 2018-04

Data Sharing

IPD Sharing
Will not share

Locations

FR(1)